𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic value of the expression of p53 and bcl-2 in patients with laryngeal carcinoma

✍ Scribed by J. Klatka


Publisher
Springer-Verlag
Year
2001
Tongue
English
Weight
36 KB
Volume
258
Category
Article
ISSN
0302-9530

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Prognostic significance of Bcl-2 and p53
✍ Michael Friedman; Jessica W. Lim; Ernie Manders; Adam D. Schaffner; Gary L. Kirs πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 79 KB πŸ‘ 1 views

## Abstract ## Background Proteins regulating the cell cycle and cell death are frequently abnormally expressed in cancer. Several of these, particularly p53 and Bcl‐2, have been widely suggested as possible prognostic markers in diverse human malignancies. Their role in predicting outcome in squa

Prognostic value of p53, bcl-2, and c-er
✍ de Krijger, Ronald R.; van der Harst, Erwin; van der Ham, Frieda; Stijnen, Theo; πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 260 KB πŸ‘ 2 views

Many studies have tried to discriminate malignant from benign phaeochromocytomas, but until now no widely accepted histological, immunohistochemical, or molecular methods have been available. In this study of 29 malignant and 85 benign phaeochromocytomas from 102 patients, immunohistochemistry was p

Clinical relevance of p53 and bcl-2 prot
✍ Giancarlo Pruneri; Lorenzo Pignataro; Nadia Carboni; Domenica Ronchetti; Bruno M πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 319 KB πŸ‘ 2 views

We investigated immunohistochemically the clinical relevance of the over-expression of the apoptosis-regulating proteins p53 and bcl-2 in a homogeneous series of 149 laryngeal squamous-cell carcinomas. p53 was over-expressed in 75 cases and bcl-2 in 39 cases. p53 and bcl-2 co-expression was found in

The prognostic significance of the bioma
✍ Ying-Tai Jin; Scott Kayser; Bonnie L. Kemp; Nelson G. Ordonez; Susan L. Tucker; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 436 KB πŸ‘ 2 views

BACKGROUND. The clinical course of laryngeal squamous cell carcinoma (LSCC) varies considerably among patients. New biologic markers are needed to facilitate the stratification of individual patients within the conventional clinicopathologic stages of LSCC. METHODS. Eighty-three LSCCs from an equal